Abstract:Renal cell carcinomas in young patients constitute a morphologically and genetically heterogeneous group. Twenty percent belong to the newly recognized Xp11.2 translocation-associated family and rare tumors arise from nephroblastoma. Aberrant Wnt signaling through beta-catenin mutation has been implicated in nephroblastoma pathogenesis and has been found to synergize with WT1 mutations. To characterize Wnt signaling activity in renal cell carcinomas in young patients, we gathered 34 tumors (three clear cell, ten Xp11.2 translocation associated, five papillary, two chromophobe, two collecting duct, one neuroblastoma associated, eight unclassified renal cell carcinomas, and three carcinomas combined with nephroblastoma) from patients less than 22 years. Expression of beta-catenin, its homologue gamma-catenin, and of WT1 was assessed by immunohistochemistry in 30 tumors, and sequence analysis of CTNNB1, CTNNG1, and WT1 genes was performed in 25 tumors. Cytoplasmic beta-catenin accumulation was demonstrated in two papillary carcinomas, one neuroblastoma-associated carcinoma, and two carcinomas arising from nephroblastoma. The pattern of gamma-catenin expression paralleled that of beta-catenin but its signal intensity was lower in 22, equal in 7, and stronger only in 1 tumor, respectively. Four tumors showed nuclear WT1 expression. One Xp11.2 translocation-associated carcinoma presented a rare intronic CTNNB1 single nucleotide polymorphism and cytoplasmic beta-catenin accumulation. There were no further CTNNB1 or CTNNG1 sequence alterations. A WT1 mutation was found in the nephroblastoma component of a carcinoma arising from nephroblastoma. These findings suggest Wnt signaling pathway activation only in a minority of renal cell carcinomas in young patients. CTNNB1 mutations are rare events. Cytoplasmic beta-catenin accumulation in an Xp11.2-associated carcinoma suggests potential interaction of Wnt signaling components with microphthalmia transcription factor family also in Xp11.2 translocation carcinomas. WT1 mutation in the nephroblastoma component of a mixed-type renal cell carcinoma provides direct evidence for clonal independence of nephroblastoma and carcinoma components in this exceptional tumor.

Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation

WT1 Mutation As a Cause of 46 XY DSD and Wilm’s Tumour: a Case Report and Literature Review

Investigating the Dysfunctional Pathogenesis of Wilms' Tumor Through a Multidimensional Integration Strategy.

Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

The oncogenic activation of β-catenin

The Wilms' Tumor 1 Gene: Oncogene or Tumor Suppressor Gene?

Role of the Wilms' Tumor 1 Gene in the Aberrant Biological Behavior of Leukemic Cells and the Related Mechanisms.

Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma.

Aberrant Wnt/β-Catenin Signaling in Pancreatic Adenocarcinoma

Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor

Wnt-independent Beta-Catenin Transactivation in Tumor Development.

Wnt signaling pathway analysis in renal cell carcinoma in young patients

Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

Wilms' Tumor 1 And Signal Transducers And Activators Of Transcription 3 Synergistically Promote Cell Proliferation: A Possible Mechanism In Sporadic Wilms' Tumor

Wnt/β-catenin Singal Transduction Pathway and Colorectal Cancer

Tumor Suppressive Role of MUC6 in Wilms Tumor Via Autophagy-Dependent Β-Catenin Degradation

Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors

Axis Inhibition Protein 2 Mutation Facilitates the Progression of Wilms' Tumor

Identification of key carcinogenic genes in Wilms' tumor